Skip to main content

Table 4 analysis B: comparison of costs between the propensity matched cases and controls B

From: The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study

Costs per day (S$)

RGNB (n = 49)

SGNB (n = 49)

p value

Median total hospitalization costs (range)

2795.9 (506.9-4882.3)

2009.6 (857.5-5213.5)

0.0004

After admission to the ICU

   

Median laboratory costs (range)

392.5 (111.1-1911.4)

203.53 (92.3-823.9)

<0.001

203.53 (92.3-823.9)

Median investigation costs(range)

147.4 (40.7-515.4)

93.9 (37.5-528.6)

0.03

Median total medication costs (range)

347.6 (87.6-1753.9)

372 (57.8-1698.9)

0.13

Median antibiotics costs (range)

82.5 (8.9-269)

39.1 (0.28-173.7)

0.004

Median Carbapenem costs (range)

35.73 (0–218.3)

12.9 (0–146.8)

0.0002

After infection

   

Median laboratory costs (range)

412.4 (53.76-4029.4)

109.8 (57.3-1131.6)

<0.001

Median investigation costs (range)

109.2 (8.6-559)

64.1 (0–279.2)

0.002

Median total medication costs (range)

584.4 (91.4-9633.6)

200.7 (53.2-1761.8)

0.0002

Median antibiotics costs (range)

146.1 (15.7-3491.9)

39.5 (0.85-572.9)

0.0001

Median Carbapenem costs (range)

56.38 (0–2040.88)

10.47 (0–211.98)

<0.001